Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Oncology March 20,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Oncology March 20,2024

Researchers develop dual anti-tumor vaccine

by The University of Hong KongFrom the left: Dr Fengwei ZHANG, Professor Billy CHOW, Professor Kelvin YEUNG, and Professor Will Wei QIAO. Credit: The University of Hong KongA research team at the

Oncology March 20,2024

Researchers develop dual anti-tumor vaccine

by The University of Hong KongFrom the left: Dr Fengwei ZHANG, Professor Billy CHOW, Professor Kelvin YEUNG, and Professor Will Wei QIAO. Credit: The University of Hong KongA research team at the

Oncology March 20,2024

Next milestone in the treatment of liver tumors and acute and chronic liver diseases

by Bianca Hermle, Universitätsklinikum TübingenGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.02.023The results of a Tübingen-led study raise hope that a newly developed d

Oncology March 20,2024

Next milestone in the treatment of liver tumors and acute and chronic liver diseases

by Bianca Hermle, Universitätsklinikum TübingenGraphical abstract. Credit:Cell(2024). DOI: 10.1016/j.cell.2024.02.023The results of a Tübingen-led study raise hope that a newly developed d

Oncology March 20,2024

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Oncology March 20,2024

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Oncology March 20,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Oncology March 20,2024

Targeting LTA4H improves the tumor immune microenvironment in ovarian cancer: Study

by Science China PressKnockdown of LTA4H resulted in an attenuated tumor growth and ascites formation. Flow cytometry results showed significantly increased ratio of M1 to M2 macrophages and perc

Oncology March 20,2024

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

Oncology March 20,2024

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic code

by Johns Hopkins University School of MedicineNew method called ARTEMIS uses machine learning to shed light on human genome "dark matter" involved in cancer and other diseases. Credit:

Oncology March 20,2024

Researchers gain insight into why T cells lose energy in solid tumors

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineGraphical Abstract. Credit:Cell Metabolism(2024). DOI: 10.1016/j.cmet.2024.02.009T cells are often ca

Oncology March 20,2024

Researchers gain insight into why T cells lose energy in solid tumors

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineGraphical Abstract. Credit:Cell Metabolism(2024). DOI: 10.1016/j.cmet.2024.02.009T cells are often ca

Oncology March 20,2024

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Oncology March 20,2024

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Oncology March 20,2024

Age-related changes in skin may contribute to melanoma metastases

by Johns Hopkins University School of MedicineAshani Weeraratna, Ph.D. Credit: Will Kirk/JHUAge-related changes that cause the skin to stiffen and become less elastic may also contribute to highe

Dermatology March 20,2024

Age-related changes in skin may contribute to melanoma metastases

by Johns Hopkins University School of MedicineAshani Weeraratna, Ph.D. Credit: Will Kirk/JHUAge-related changes that cause the skin to stiffen and become less elastic may also contribute to highe

Dermatology March 20,2024

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident

Oncology March 20,2024

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident

Oncology March 20,2024